Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Gehring MP"'
Autor:
Gomez-Soler M; Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA., Gehring MP; Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA., Lechtenberg BC; Ubiquitin Signalling Division, The Walter and Eliza Hall Institute of Medical Research, Parkville Victoria 3052, Australia and Department of Medical Biology, The University of Melbourne, Parkville, Victoria 3010, Australia., Zapata-Mercado E; Department of Materials Science and Engineering, Johns Hopkins University, Baltimore, MD 21218, USA., Ruelos A; Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA., Matsumoto MW; Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA., Hristova K; Department of Materials Science and Engineering, Johns Hopkins University, Baltimore, MD 21218, USA., Pasquale EB; Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA.
Publikováno v:
IScience [iScience] 2022 Feb 04; Vol. 25 (3), pp. 103870. Date of Electronic Publication: 2022 Feb 04 (Print Publication: 2022).
Autor:
Lechtenberg BC; Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, 92037, USA. lechtenberg.b@wehi.edu.au.; Ubiquitin Signalling Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia. lechtenberg.b@wehi.edu.au.; Department of Medical Biology, The University of Melbourne, Parkville, VIC, 3010, Australia. lechtenberg.b@wehi.edu.au., Gehring MP; Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, 92037, USA., Light TP; Department of Materials Science and Engineering, Institute for NanoBioTechnology, Johns Hopkins University, 3400 Charles Street, Baltimore, MD, 21218, USA., Horne CR; Ubiquitin Signalling Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, VIC, 3010, Australia., Matsumoto MW; Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, 92037, USA., Hristova K; Department of Materials Science and Engineering, Institute for NanoBioTechnology, Johns Hopkins University, 3400 Charles Street, Baltimore, MD, 21218, USA., Pasquale EB; Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, 92037, USA. elenap@sbpdiscovery.org.
Publikováno v:
Nature communications [Nat Commun] 2021 Dec 02; Vol. 12 (1), pp. 7047. Date of Electronic Publication: 2021 Dec 02.
Autor:
Light TP; Department of Materials Science and Engineering, Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, Maryland, USA., Gomez-Soler M; Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA., Wang Z; Department of Chemistry, Center for Biophysics and Quantitative Biology, Beckman Institute for Advanced Science and Technology, and National Center for Supercomputing Applications, School of Chemical Sciences, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA., Karl K; Program in Molecular Biophysics, Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, Maryland, USA., Zapata-Mercado E; Program in Molecular Biophysics, Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, Maryland, USA., Gehring MP; Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA., Lechtenberg BC; Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA., Pogorelov TV; Department of Chemistry, Center for Biophysics and Quantitative Biology, Beckman Institute for Advanced Science and Technology, and National Center for Supercomputing Applications, School of Chemical Sciences, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA., Hristova K; Department of Materials Science and Engineering, Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, Maryland, USA; Program in Molecular Biophysics, Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, Maryland, USA. Electronic address: kalina.hristova@jhu.edu., Pasquale EB; Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA. Electronic address: elenap@sbpdiscovery.org.
Publikováno v:
The Journal of biological chemistry [J Biol Chem] 2021 Jul; Vol. 297 (1), pp. 100876. Date of Electronic Publication: 2021 Jun 15.
Autor:
Gehring MP; Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA., Pasquale EB; Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA. Electronic address: elenap@sbpdiscovery.org.
Publikováno v:
Cellular signalling [Cell Signal] 2020 Sep; Vol. 73, pp. 109668. Date of Electronic Publication: 2020 May 13.
Autor:
Santos AA Jr; Programa de Pós-Graduação em Biologia Celular e Molecular, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil., Cappellari AR; Programa de Pós-Graduação em Biologia Celular e Molecular, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil., de Marchi FO; Faculdade de Farmácia, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil., Gehring MP; Programa de Pós-Graduação em Biologia Celular e Molecular, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil., Zaparte A; Programa de Pós-graduação em Medicina e Ciências da Saúde, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil., Brandão CA; Faculdade de Medicina, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil., Lopes TG; Hospital São Lucas da PUCRS, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil., da Silva VD; Programa de Pós-graduação em Medicina e Ciências da Saúde, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil.; Faculdade de Medicina, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil.; Hospital São Lucas da PUCRS, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil., Pinto LFR; Programa de Carcinogênese Molecular, Coordenação de Pesquisa, Instituto Nacional do Câncer (INCA), Rio de Janeiro, Brazil.; Departamento de Bioquímica, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil., Savio LEB; Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil., Moreira-Souza ACA; Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil., Coutinho-Silva R; Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil., Paccez JD; International Centre for Genetic Engineering and Biotechnology (ICGEB), Cancer Genomics Group, Cape Town, South Africa., Zerbini LF; International Centre for Genetic Engineering and Biotechnology (ICGEB), Cancer Genomics Group, Cape Town, South Africa.; Department of Integrative Biomedical Sciences, University of Cape Town, Cape Town, South Africa., Morrone FB; Programa de Pós-Graduação em Biologia Celular e Molecular, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil. fernanda.morrone@pucrs.br.; Faculdade de Farmácia, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil. fernanda.morrone@pucrs.br.; Programa de Pós-graduação em Medicina e Ciências da Saúde, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil. fernanda.morrone@pucrs.br.
Publikováno v:
Purinergic signalling [Purinergic Signal] 2017 Sep; Vol. 13 (3), pp. 279-292. Date of Electronic Publication: 2017 Apr 11.
Autor:
Patnaik A; Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Dana Farber/Harvard Cancer Center, Harvard Medical School, Boston, Massachusetts. apatnaik1@uchicago.edu.; Beth Israel Deaconess Cancer Center, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.; Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois.; The University of Chicago Comprehensive Cancer Center, Chicago, Illinois., Swanson KD; Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts., Csizmadia E; Division of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Solanki A; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Harvard Stem Cell Institute, Boston, Massachusetts., Landon-Brace N; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Harvard Stem Cell Institute, Boston, Massachusetts., Gehring MP; Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.; Laboratório de Farmacologia Aplicada, PUCRS, Porto Alegre, Brazil., Helenius K; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts., Olson BM; Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois.; The University of Chicago Comprehensive Cancer Center, Chicago, Illinois., Pyzer AR; Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Dana Farber/Harvard Cancer Center, Harvard Medical School, Boston, Massachusetts., Wang LC; Meyer Cancer Center, Weill Cornell Medical College, New York, New York., Elemento O; Meyer Cancer Center, Weill Cornell Medical College, New York, New York., Novak J; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Thornley TB; Transplant Institute and Immunology Program, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts., Asara JM; Division of Signal Transduction, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts., Montaser L; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts., Timmons JJ; Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts., Morgan TM; Department of Urology, University of Michigan, Ann Arbor, Michigan., Wang Y; Department of Urology, University of Michigan, Ann Arbor, Michigan., Levantini E; Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Dana Farber/Harvard Cancer Center, Harvard Medical School, Boston, Massachusetts.; Harvard Stem Cell Institute, Boston, Massachusetts.; Institute of Biomedical Technologies, National Research Council (CNR), Pisa, Italy., Clohessy JG; Beth Israel Deaconess Cancer Center, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.; Preclinical Murine Pharmacogenetics Facility, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts., Kelly K; Laboratory of Genitourinary Cancer Pathogenesis, National Cancer Institute, Bethesda, Maryland., Pandolfi PP; Beth Israel Deaconess Cancer Center, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts., Rosenblatt JM; Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Dana Farber/Harvard Cancer Center, Harvard Medical School, Boston, Massachusetts.; Beth Israel Deaconess Cancer Center, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts., Avigan DE; Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Dana Farber/Harvard Cancer Center, Harvard Medical School, Boston, Massachusetts.; Beth Israel Deaconess Cancer Center, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts., Ye H; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts., Karp JM; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Harvard Stem Cell Institute, Boston, Massachusetts., Signoretti S; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Balk SP; Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Dana Farber/Harvard Cancer Center, Harvard Medical School, Boston, Massachusetts.; Beth Israel Deaconess Cancer Center, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts., Cantley LC; Meyer Cancer Center, Weill Cornell Medical College, New York, New York.
Publikováno v:
Cancer discovery [Cancer Discov] 2017 Jul; Vol. 7 (7), pp. 750-765. Date of Electronic Publication: 2017 Mar 08.
Autor:
Morrone FB; Programa de Pós-graduação em Biologia Celular e Molecular (F.B.M., M.P.G., N.F.N), Programa de Pós-graduação em Medicina e Ciências da Saúde, Faculdade de Farmácia, Pontifícia Universidade Católica do RS, Porto Alegre (F.B.M.); Laboratório de Terapia Celular, Centro de Ciências Biológicas e da Saúde, Universidade de Caxias do Sul, Caxias do Sul (N.F.N.), Brasil fernanda.morrone@pucrs.br., Gehring MP; Programa de Pós-graduação em Biologia Celular e Molecular (F.B.M., M.P.G., N.F.N), Programa de Pós-graduação em Medicina e Ciências da Saúde, Faculdade de Farmácia, Pontifícia Universidade Católica do RS, Porto Alegre (F.B.M.); Laboratório de Terapia Celular, Centro de Ciências Biológicas e da Saúde, Universidade de Caxias do Sul, Caxias do Sul (N.F.N.), Brasil., Nicoletti NF; Programa de Pós-graduação em Biologia Celular e Molecular (F.B.M., M.P.G., N.F.N), Programa de Pós-graduação em Medicina e Ciências da Saúde, Faculdade de Farmácia, Pontifícia Universidade Católica do RS, Porto Alegre (F.B.M.); Laboratório de Terapia Celular, Centro de Ciências Biológicas e da Saúde, Universidade de Caxias do Sul, Caxias do Sul (N.F.N.), Brasil.
Publikováno v:
Molecular pharmacology [Mol Pharmacol] 2016 Sep; Vol. 90 (3), pp. 403-9. Date of Electronic Publication: 2016 Jul 14.
Autor:
Gehring MP; PUCRS, Programa de Pós-Graduação em Biologia Celular e Molecular, Laboratório de Farmacologia Aplicada, Av. Ipiranga, 6681, 90619-900 Porto Alegre, RS, Brazil. Electronic address: marinapgehring@gmail.com., Kipper F; Laboratório de Sinalização e Plasticidade Celular, UFRGS, Av. Bento Gonçalves, 9500, 91501-970 Porto Alegre, RS, Brazil. Electronic address: franciele.kipper@yahoo.com.br., Nicoletti NF; PUCRS, Programa de Pós-Graduação em Biologia Celular e Molecular, Laboratório de Farmacologia Aplicada, Av. Ipiranga, 6681, 90619-900 Porto Alegre, RS, Brazil. Electronic address: natifn@gmail.com., Sperotto ND; PUCRS, Programa de Pós-Graduação em Biologia Celular e Molecular, Laboratório de Farmacologia Aplicada, Av. Ipiranga, 6681, 90619-900 Porto Alegre, RS, Brazil. Electronic address: nati.sperotto@hotmail.com., Zanin R; PUCRS, Programa de Pós-Graduação em Biologia Celular e Molecular, Laboratório de Farmacologia Aplicada, Av. Ipiranga, 6681, 90619-900 Porto Alegre, RS, Brazil. Electronic address: rafaelzaninn@gmail.com., Tamajusuku AS; Laboratório de Sinalização e Plasticidade Celular, UFRGS, Av. Bento Gonçalves, 9500, 91501-970 Porto Alegre, RS, Brazil. Electronic address: alessandratamajusuku@unipampa.edu.br., Flores DG; Cancer Research Laboratory, University Hospital Research Center (CPE-HCPA), Porto Alegre, RS, Brazil. Electronic address: dgazzanaf@unisinos.br., Meurer L; Departamento de Patologia, HCPA, UFRGS, Rua Ramiro Barcelos, 2350, 90420-010 Porto Alegre, RS, Brazil. Electronic address: lmeurer@terra.com.br., Roesler R; Laboratory of Neuropharmacology and Neural Tumor Biology, Department of Pharmacology, Institute for Basic Health Sciences, UFRGS, Porto Alegre, RS, Brazil; Cancer Research Laboratory, University Hospital Research Center (CPE-HCPA), UFRGS, Porto Alegre, RS, Brazil; National Institute for Translational Medicine, Rua Sarmento Leite, 500, Sala 202, 90050-170 Porto Alegre, RS, Brazil. Electronic address: rroesler@terra.com.br., Filho AB; Serviço de Radioterapia, Hospital São Lucas da PUCRS, Av. Ipiranga, 6681, 90619-900 Porto Alegre, RS, Brazil. Electronic address: aroldoradioterapia@terra.com.br., Lenz G; Laboratório de Sinalização e Plasticidade Celular, UFRGS, Av. Bento Gonçalves, 9500, 91501-970 Porto Alegre, RS, Brazil. Electronic address: gulenz@gmail.com., Campos MM; PUCRS, Instituto de Toxicologia e Farmacologia e Faculdade de Odontologia, Av. Ipiranga, 6681, 90619-900 Porto Alegre, RS, Brazil. Electronic address: maria.campos@pucrs.br., Morrone FB; PUCRS, Programa de Pós-Graduação em Biologia Celular e Molecular, Laboratório de Farmacologia Aplicada, Av. Ipiranga, 6681, 90619-900 Porto Alegre, RS, Brazil. Electronic address: fernanda.morrone@pucrs.br.
Publikováno v:
The international journal of biochemistry & cell biology [Int J Biochem Cell Biol] 2015 Nov; Vol. 68, pp. 92-100. Date of Electronic Publication: 2015 Sep 08.
Autor:
Gehring MP; Laboratório de Farmacologia Aplicada, PUCRS, Av. Ipiranga, 6681, Prédio 12C, Sala 148, Partenon, Porto Alegre, RS, Brazil., Pereira TC, Zanin RF, Borges MC, Braga Filho A, Battastini AM, Bogo MR, Lenz G, Campos MM, Morrone FB
Publikováno v:
Purinergic signalling [Purinergic Signal] 2012 Dec; Vol. 8 (4), pp. 729-39. Date of Electronic Publication: 2012 May 28.